Profile of parotid cancers at the ENT clinic Lamine Sine Diop of Fann teaching hospital
DOI:
https://doi.org/10.54266/ajo.1.2.55.WMWE8515Keywords:
Parotid, Cancer, Parotidectomy, RadiotherapyAbstract
INTRODUCTION: Parotid cancers are characterized by a great histological diversity and they pose diagnostic, therapeutic and evolutionary problems. We deliver through this study our experience on the management of malignant parotid tumors. MATERIALS AND METHODS: This is a retrospective, descriptive and analytical study carried out over a period of 12 years in the ENT department of Fann teaching hospital. RESULTS: The mean age at diagnosis was 48 years with a sex-ratio of 1.6. The time to symptom progression was approximately 47 months. Parotid swelling was present in all patients and peripheral facial palsy was found in 31% of patients. Ultrasound of the parotid region was performed in 11 patients, i.e. 34%, and computed tomography in 18 patients, i.e. 56%. Fine needle aspiration was performed in 11 patients. Parotid cancers accounted for 44% of all parotid tumors. Sixty-eight percent of patients consulted at the T4 stage. Seventy-one percent of patients received surgical treatment. The most common histologic type was muco-epidermoid carcinoma. Five patients received radiotherapy. The postoperative effects were dominated by PFP (18%). Seven cases of death were recorded. CONCLUSION: The management of parotid cancer still poses diagnostic and above all therapeutic problems. The combination of radiotherapy surgery, very rarely encountered in our study, provides a better prognosis and better survival.
References
Diom ES, Thiam A, Tall A, Ndiaye M, Toure S, Diouf R. Profil des tumeurs de la glande parotide : expérience sur 93 cas colligés en 16 ans. Annales françaises d’Oto-rhino-laryngologie et de Pathologie Cervico-faciale. févr 2015;132(1):9‑12. DOI: 10.1016/j.aforl.2014.08.001
Gola R, Chossegros C, Carreau P. [Surgical anatomy of the parotid region. Current concepts]. Rev Stomatol Chir Maxillofac. 1994;95(6):395‑410.
Van Lierop AC, Fagan JJ. Parotidectomy in Cape Town--a review of pathology and management. S Afr J Surg. août 2007;45(3):96‑8, 100, 102‑3.
Diom ES, Déguenonvo R, Tall A, Ndiaye M, Diop A. Aspects chirurgicaux des cancers parotidiens au Sénégal : A propos de 30 cas. RevCAMES. 13(1):63‑5.
Erovic BM, Shah MD, Bruch G, Johnston M, Kim J, O’Sullivan B, et al. Outcome analysis of 215 patients with parotid gland tumors: A retrospective cohort analysis. Journal of Otolaryngology - Head & Neck Surgery. janv 2015;44(1):43. DOI: 10.1186/s40463-015-0097-z
Bouaity B, Darouassi* Y, Chihani M, Touati MM, Ammar H. Les facteurs prédictifs de malignité dans la prise en charge des tumeurs parotidiennes: à propos de 76 cas. Pan Afr Med J [Internet]. 2016 [cité 28 févr 2024];23. Disponible sur: http://www.panafrican-med-journal.com/content/article/23/112/full/ DOI: 10.11604/pamj.2016.23.112.8404
De Vincentiis M, Magliulo G, Soldo P, Manciocco V, Pagliuca G, Del Gaizo R, et al. Extended parotidectomy. Acta Otorhinolaryngol Ital. juin 2005;25(3):169‑73.
Beltaief N, Tababi S, Atallah S, Ben Mansour MH, Ouertatani L, Charfi A, et al. Les Tumeurs Malignes De La Parotide. Journal Tunisien d’ORL et de Chirurgie Cervico-Faciale. juin 2007;(18):25‑8.
Bouyon A, Hans S, Durdux C, Housset M. Tumeurs malignes de la parotide: prise en charge multidisciplinaire, rôle de la radiothérapie. Cancer/Radiothérapie. déc 2007;11(8):465‑75. DOI: 10.1016/j.canrad.2007.07.002
Cracchiolo JR, Shaha AR. Parotidectomy for Parotid Cancer. Otolaryngologic Clinics of North America. avr 2016;49(2):415‑24. DOI: 10.1016/j.otc.2015.10.007
Spiro RH. Management of malignant tumors of the salivary glands. Oncology (Williston Park). mai 1998;12(5):671‑80; discussion 683.
Prades JM, Oletski A, Timoshenko AP, Veyret C, Martin C. Morphologie IRM des tuméfactions de la glande parotide : corrélation anatomo-clinique. Morphologie. juin 2006;90(289):108. DOI: 10.1016/S1286-0115(06)74473-3
Ikoma R, Ishitoya J, Sakuma Y, Hirama M, Shiono O, Komatsu M, et al. Temporary facial nerve dysfunction after parotidectomy correlates with tumor location. Auris Nasus Larynx. oct 2014;41(5):479‑84. DOI: 10.1016/j.anl.2014.05.001
Bruneton JN, Mourou MY. Ultrasound in Salivary Gland Disease. ORL. 1993;55(5):284‑9. DOI: 10.1159/000276440
Raine C, Saliba K, Chippindale AJ, McLean NR. Radiological imaging in primary parotid malignancy. British Journal of Plastic Surgery. oct 2003;56(7):637‑43. DOI: 10.1016/s0007-1226(03)00358-8
Maruo T, Fujimoto Y, Yoshida K, Hiramatsu M, Suzuki A, Nishio N, et al. Effect of clinical symptoms on the indication for selective neck dissection for N0 carcinomas of the parotid gland. Oncology Letters. juill 2014;8(1):335‑8. DOI: 10.3892/ol.2014.2137
Longuet M, Nallet E, Guedon C, Depondt J, Gehanno P, Barry B. Valeur diagnostique de la cytoponction et de l’examen histologique extemporané dans les tumeurs parotidiennes primitives opérées. Revue De Laryngologie - Otologie - Rhinologie. 2001;122(1):51‑5.
Lim CM, They J, Loh KS, Chao SS, Lim LHY, Tan LKS. Role of fine‐needle aspiration cytology in the evaluation of parotid tumors. ANZ Journal of Surgery. sept 2007;77(9):742‑4. DOI: 10.1111/j.1445-2197.2007.04222.x
Sood S, McGurk M, Vaz F. Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. mai 2016;130(S2):S142‑9. DOI: 10.1017/S0022215116000566
Lee DH, Yoon TM, Lee JK, Lim SC. Clinicopathologic factors associated with recurrence in parotid carcinoma. Brazilian Journal of Otorhinolaryngology. nov 2018;84(6):691‑6. DOI: 10.1016/j.bjorl.2017.08.003
Paris J, Coulet O, Facon F, Chrestian MA, Giovanni A, Zanaret M. Cancers primitifs de la parotide : approche anatomo-clinique. Revue De Stomatologie Et De Chirurgie Maxillo-Faciale. déc 2004;105(6):309‑15.
Venkatesh S, Srinivas T, Hariprasad S. Parotid gland tumors: 2-year prospective clinicopathological study. Ann Maxillofac Surg. 2019;9(1):103. DOI: 10.4103/ams.ams_179_18
Diop E, Hitimana A, Diouf R, Diop LS. Bilan de 40 parotidectomies. Rev Laryngol Otol Rhinol. 1984;(105):25‑31.
Harish K. Management of primary malignant epithelial parotid tumors. Surgical Oncology. juill 2004;13(1):7‑16. DOI: 10.1016/j.suronc.2003.10.002
Kaur J, Goyal S, Muzumder S, Bhasker S, Mohanti BK, Rath GK. Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute. Asian Pacific Journal of Cancer Prevention. 23 oct 2014;15(19):8259‑63. DOI: 10.7314/apjcp.2014.15.19.8259
Terhaard CHJ, Lubsen H, Rasch CRN, Levendag PC, Kaanders HHÀM, Tjho-Heslinga RE, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. International Journal of Radiation Oncology*Biology*Physics. janv 2005;61(1):103‑11. DOI: 10.1016/j.ijrobp.2004.03.018
Jin H, Kim BY, Kim H, Lee E, Park W, Choi S, et al. Incidence of postoperative facial weakness in parotid tumor surgery: a tumor subsite analysis of 794 parotidectomies. BMC Surg. déc 2019;19(1):199. DOI: 10.1186/s12893-019-0666-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 African Journal of Oncology
This work is licensed under a Creative Commons Attribution 4.0 International License.
